173 related articles for article (PubMed ID: 26382848)
1. Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma.
Gzell C; Wheeler H; Huang D; Gaur P; Chen J; Kastelan M; Back M
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):215-22. PubMed ID: 26382848
[TBL] [Abstract][Full Text] [Related]
2. Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?
Azizi AA; Paur S; Kaider A; Dieckmann K; Peyrl A; Chocholous M; Czech T; Slavc I
Strahlenther Onkol; 2018 Jun; 194(6):552-559. PubMed ID: 29349602
[TBL] [Abstract][Full Text] [Related]
3. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series.
Rusthoven KE; Olsen C; Franklin W; Kleinschmidt-DeMasters BK; Kavanagh BD; Gaspar LE; Lillehei K; Waziri A; Damek DM; Chen C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):211-7. PubMed ID: 20732762
[TBL] [Abstract][Full Text] [Related]
4. Debulking or biopsy of malignant glioma in elderly people - a randomised study.
Vuorinen V; Hinkka S; Färkkilä M; Jääskeläinen J
Acta Neurochir (Wien); 2003 Jan; 145(1):5-10. PubMed ID: 12545256
[TBL] [Abstract][Full Text] [Related]
5. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
6. Current knowledge and treatment strategies for grade II gliomas.
Narita Y
Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
[TBL] [Abstract][Full Text] [Related]
8. Invasion is not an independent prognostic factor in high-grade glioma.
Narayana A; Perretta D; Kunnakkat S; Gruber D; Golfinos J; Parker E; Medabalmi P; Zagzag D; Pat Eagan RN; Gruber M
J Cancer Res Ther; 2011; 7(3):331-5. PubMed ID: 22044816
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
10. Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.
Back M; Jayamanne DT; Brazier D; Newey A; Bailey D; Schembri GP; Hsiao E; Khasraw M; Wong M; Kastelan M; Guo L; Clarke S; Wheeler H
J Med Imaging Radiat Oncol; 2019 Apr; 63(2):272-280. PubMed ID: 30677248
[TBL] [Abstract][Full Text] [Related]
11. Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas.
Guram K; Smith M; Ginader T; Bodeker K; Pelland D; Pennington E; Buatti JM
Pract Radiat Oncol; 2019 Jan; 9(1):16-23. PubMed ID: 30195927
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
13. [Intraoperative radiotherapy of brain gliomas].
Kofler A; Fritsch E; Maier H; Kamleitner H; Kostron H
Wien Klin Wochenschr; 1990 Sep; 102(18):528-31. PubMed ID: 2264344
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
[TBL] [Abstract][Full Text] [Related]
15. Trends in peri-operative performance status following resection of high grade glioma and brain metastases: The impact on survival.
Patel CK; Vemaraju R; Glasbey J; Shires J; Northmore T; Zaben M; Hayhurst C
Clin Neurol Neurosurg; 2018 Jan; 164():67-71. PubMed ID: 29197281
[TBL] [Abstract][Full Text] [Related]
16. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
17. The effect of waiting for radiotherapy for grade III/IV gliomas.
Do V; Gebski V; Barton MB
Radiother Oncol; 2000 Nov; 57(2):131-6. PubMed ID: 11054516
[TBL] [Abstract][Full Text] [Related]
18. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
[TBL] [Abstract][Full Text] [Related]
19. Relationship of intraoperative ultrasound characteristics with pathological grades and Ki-67 proliferation index in intracranial gliomas.
Baskan O; Silav G; Sari R; Canoz O; Elmaci I
J Med Ultrason (2001); 2015 Apr; 42(2):231-7. PubMed ID: 26576577
[TBL] [Abstract][Full Text] [Related]
20. The management of patients with an intrinsic supratentorial brain tumour.
Sandeman DR; Sandeman AP; Buxton P; Hughes HH; Chadwick DW; Williams IR; Baker RD; Foy PM; Shaw DM
Br J Neurosurg; 1990; 4(4):299-312. PubMed ID: 2222876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
